Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabeth Farrelly

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Scandinavian Journal of Urology|July 19, 2021
The Stockholm Spinal Cord Uro Study: 3. Urodynamic characteristics in a regional prevalence group of persons with spinal cord injury and indications for improved follow-upElisabeth Farrelly, Lena Lindbo, Åke Seiger
Scandinavian Journal of Urology|October 24, 2024
The Stockholm Spinal Cord Uro Study: Changing patterns of urological surgery in a regional prevalence group through 50 years - Outcomes and lessons learnedElisabeth Farrelly, Lena Lindbo, Åke Seiger
Scandinavian Journal of Urology|March 10, 2020
The Stockholm Spinal Cord Uro Study: 2. Urinary tract infections in a regional prevalence group: frequency, symptoms and treatment strategiesElisabeth Farrelly, Lena Lindbo, Hans Wijkström, et al.
Scandinavian Journal of Urology|October 22, 2019
The Stockholm Spinal Cord Uro Study: 1. Basic characteristics and problem inventoryElisabeth Farrelly, Lena Lindbo, Hans Wijkström, et al.
Scandinavian Journal of Urology and Nephrology|September 1, 2007
Efficacy and impact of botulinum toxin A on quality of life in patients with neurogenic detrusor overactivity: a randomised, placebo-controlled, double-blind studyIngrid Ehren, Daniela Volz, Elisabeth Farrelly, et al.
Urology|August 11, 2004
Efficacy and safety of a novel system (NASHA/Dx copolymer using the Implacer device) for treatment of stress urinary incontinencePhilip van Kerrebroeck, Flip ter Meulen, Gregor Larsson, et al.
Urological Research|February 25, 2003
Treatment of stress urinary incontinence: recent developments in the role of urethral injectionPhilip van Kerrebroeck, Flip ter Meulen, Elisabeth Farrelly, et al.
International Urogynecology Journal|July 29, 2020
OnabotulinumtoxinA is a well tolerated and effective treatment for refractory overactive bladder in real-world practiceRizwan Hamid, Maria-Fernanda Lorenzo-Gomez, Heinrich Schulte-Baukloh, et al.
BJU International|November 16, 2004
Treatment of stress urinary incontinence using a copolymer system: impact on quality of lifePhilip van Kerrebroeck, Flip ter Meulen, Gregor Larsson, et al.
Neurourology and Urodynamics|June 1, 2023
One treatment with onabotulinumtoxinA relieves symptoms of overactive bladder in patients refractory to one or more oral medicationsElisabeth Farrelly, Rizwan Hamid, Maria-Fernanda Lorenzo-Gomez, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Scandinavian Journal of Urology|July 19, 2021
The Stockholm Spinal Cord Uro Study: 3. Urodynamic characteristics in a regional prevalence group of persons with spinal cord injury and indications for improved follow-upElisabeth Farrelly, Lena Lindbo, Åke Seiger
Scandinavian Journal of Urology|October 24, 2024
The Stockholm Spinal Cord Uro Study: Changing patterns of urological surgery in a regional prevalence group through 50 years - Outcomes and lessons learnedElisabeth Farrelly, Lena Lindbo, Åke Seiger
Scandinavian Journal of Urology|March 10, 2020
The Stockholm Spinal Cord Uro Study: 2. Urinary tract infections in a regional prevalence group: frequency, symptoms and treatment strategiesElisabeth Farrelly, Lena Lindbo, Hans Wijkström, et al.
Scandinavian Journal of Urology|October 22, 2019
The Stockholm Spinal Cord Uro Study: 1. Basic characteristics and problem inventoryElisabeth Farrelly, Lena Lindbo, Hans Wijkström, et al.
Scandinavian Journal of Urology and Nephrology|September 1, 2007
Efficacy and impact of botulinum toxin A on quality of life in patients with neurogenic detrusor overactivity: a randomised, placebo-controlled, double-blind studyIngrid Ehren, Daniela Volz, Elisabeth Farrelly, et al.
Urology|August 11, 2004
Efficacy and safety of a novel system (NASHA/Dx copolymer using the Implacer device) for treatment of stress urinary incontinencePhilip van Kerrebroeck, Flip ter Meulen, Gregor Larsson, et al.
Urological Research|February 25, 2003
Treatment of stress urinary incontinence: recent developments in the role of urethral injectionPhilip van Kerrebroeck, Flip ter Meulen, Elisabeth Farrelly, et al.
International Urogynecology Journal|July 29, 2020
OnabotulinumtoxinA is a well tolerated and effective treatment for refractory overactive bladder in real-world practiceRizwan Hamid, Maria-Fernanda Lorenzo-Gomez, Heinrich Schulte-Baukloh, et al.
BJU International|November 16, 2004
Treatment of stress urinary incontinence using a copolymer system: impact on quality of lifePhilip van Kerrebroeck, Flip ter Meulen, Gregor Larsson, et al.
Neurourology and Urodynamics|June 1, 2023
One treatment with onabotulinumtoxinA relieves symptoms of overactive bladder in patients refractory to one or more oral medicationsElisabeth Farrelly, Rizwan Hamid, Maria-Fernanda Lorenzo-Gomez, et al.
Pageof 1